IGHV4-39 deletion polymorphism does not associate with risk or outcome of multiple sclerosis.
Journal of neuroimmunology 2010 Aug 225 (1-2): 164-6.
Watson Corey T, Ramagopalan Sreeram V, Morrison Katie M, Ebers George C, Breden Fel
- Page last reviewed:Jul 30, 2019
- Page last updated:Sep 18, 2019
- Content source: